Epizyme
EPZM
$1.47
Share price
0.00%
Change (1 day)
-65.57%
Change (1 year)
Categories
Market capitalization of Epizyme (EPZM)
Market cap: $0.24 Billion
As of April 2024 Epizyme has a market cap of $0.24 Billion. This makes Epizyme the world's 6729th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Epizyme from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.24 B | |
| 2022 | $0.24 B | -6.69% |
| 2021 | $0.26 B | -75.96% |
| 2020 | $1.10 B | -54.14% |
| 2019 | $2.40 B | 393.21% |
| 2018 | $0.48 B | -43.91% |
| 2017 | $0.86 B | 23.87% |
| 2016 | $0.70 B | 4.86% |
| 2015 | $0.66 B | 3.05% |
| 2014 | $0.64 B | 9.63% |
| 2013 | $0.59 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $198.81 B | 80,231.44% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $186.58 B | 75,288.49% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $83.98 B | 33,835.41% | 🇬🇧 UK |
 Seagen
SGEN | $43.15 B | 17,336.52% | 🇺🇸 USA |